BiotechTube
Home/Hetero/Dr. R. K. Mishra
DR

Dr. R. K. Mishra

Chief Scientific Officer

Hetero

Therapeutic Areas

Infectious DiseasesVirologyAntiretroviralBiosimilars

Hetero Pipeline

DrugIndicationPhase
Movfor (Molnupiravir)COVID‑19Phase 3
Nirmatrelvir/Ritonavir GenericCOVID‑19Commercial
Tenofovir Disoproxil FumarateHIVCommercial
Trastuzumab BiosimilarHER2‑positive Breast CancerPhase 3

Leadership Team at Hetero

DP
Dr. Prashant S. Singh
MD & CEO
View full Hetero profile